INmune Bio Inc.
BioTech/Drugs - San Diego, CA, US
INmune Bio Inc. Senior Management
INmune Bio Inc. Details
INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient's immune system to treat cancer. INKmune, the company's lead product, primes patient's NK cells (natural killer cells) to kill cancer. INmune is targeting residual disease, the cancer cells that survive initial treatments that return to cause the cancer relapse. By controlling residual disease, patients may live longer. Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.Media coverage provided for informational purposes only and third party links provided as a resource. INmune Bio does not control the content of third parties. XPro1595, Quellor, LIVNate, INB03, INKmune and other drug candidates, have not yet been shown to be safe or effective, and has not been approved by any regulatory body.
INmune Bio Inc. Technologies
Email Providers
Outlook
Widgets
Google translate API
Load Balancers
Apache
Tag Management
Google Tag Manager
Other
Microsoft Office 365
CSS and JavaScript Libraries
Amcharts JS Library